Compound medicament for treating synovitis

A synovitis and drug technology, applied in the direction of drug combination, antipyretics, anti-inflammatory agents, etc., can solve the problem of no specific therapy, achieve the effect of improving microcirculation disorder and good therapeutic effect

Inactive Publication Date: 2008-06-18
杨纪英
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] In summary, there is no effective therapy for

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024]Example 1: Ms. He, 60 years old, suffered pain in both knee joints for more than six years, accompanied by joint fear of cold and wind. In the past 2 years, her knee joints were swollen and effusion, and it was difficult to go up and down stairs. Diagnosed as senile osteoarthritis with synovitis, with the following prescription:

[0025] Oral administration: Atractylodes 10g, Phellodendron 10g, Fangji 20g, Papaya 20g, Wujiapi 10g, Clematis 10g, Duhuo 10g, Radix Paeoniae Alba 10g, Astragalus 30g, Coix seed 60g, Codonopsis 30g, Angelica dahurica 8g, Guizhi 8g;

[0026] External application: 2g Aconitum, 5g Aconitum, 20g notopterygium, 10g safflower, 10g Fangfeng, 10g cassia twig, 2g mulberry branch, 5g atractylodes atractylodes, 10g aconite, 5g epimedium, 20g Speranthema, 10g lovuo, 10g Baizhi, Asarum 10g.

[0027] One treatment is effective, and the fear of cold and wind in the knee joint is alleviated. After taking it orally and applying it externally twice, the patient...

Embodiment 2

[0028] Embodiment 2: Mr. Huang, 50 years old, was diagnosed as ankle joint synovitis by many hospitals because of double ankle joint redness, swelling and heat pain, with following prescription:

[0029] Oral administration: Atractylodes 15g, Phellodendron 15g, Fangji 15g, Papaya 15g, Wujiapi 15g, Clematis 15g, Duhuo 15g, Radix Paeoniae Alba 15g, Astragalus 40g, Coix seed 40g, Codonopsis 40g, Angelica dahurica 10g, Guizhi 10g.

[0030] External application: 15g Aconitum, 10g Aconitum, 15g notopterygium, 10g safflower, 15g Fangfeng, 10g cassia twig, 5g mulberry branch, 10g atractylodes atractylodes, 10g aconite, 10g Epimedium, 20g Speranthum, 20g Duhuo, 20g Angelica, Asarum 20g.

[0031] After 20 days of medication, the symptoms were significantly relieved, and after 30 days, the symptoms disappeared.

Embodiment 3

[0032] Embodiment 3: Ms. Shi, 52 years old, suffered from joint pain and pain all over the body for more than 3-4 years. She took various painkillers for a long time, and was still taking painkillers when she was not diagnosed. The rheumatoid factor (+) was checked by laboratory tests Increased erythrocyte sedimentation rate, normal anti-"O", morning stiffness greater than 1 hour, clinical diagnosis: rheumatoid arthritis, with the following prescription:

[0033] Oral administration: Atractylodes 20g, Phellodendron 20g, Fangji 20g, Papaya 20g, Wujiapi 10g, Clematis 10g, Duhuo 10g, Radix Paeoniae Alba 10g, Astragalus 30g, Coix Seed 30g, Codonopsis 30g, Angelica dahurica 10g, Guizhi 10g;

[0034] External application: 10g Aconitum, 10g Aconitum, 10g notopterygium, 10g safflower, 10g Fangfeng, 10g cassia twig, 2g mulberry branch, 5g atractylodes atractylodes, 10g aconite, 5g Epimedium, 10g Speranthema, 10g lovuo, 10g Angelica dahurica, Asarum 10g.

[0035] After a course of trea...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a combined drug for treating synovitis, including an oral drug and an external application drug. The part rate of the oral drug is that Rhizoma Atractylodis 10-20 parts, Cortex Phellodendri 10-20 parts, Radix Stephaniae Tetrandrae 10-20 parts, Chaenomeles sinensis 10-20 parts, Harms Manyprickle Acanthopanax 10-20 parts, Radix Clematidis Chinensis 10-20 parts, Radix Angelicae Pubescentis 10-20 parts, Radix Paeoniae Alba 10-20 parts, Radix Astragali 30-60 parts, Semen Coicis 30-60 parts, Radix Codonopsis 30-60 parts, Radix Angelicae Dahuricae 8-15 parts and Ramulus Cinnamomi 8-15 parts. The part rate of the external application drug is that Radix Aconiti Kusnezoffii 2-20 parts, Radix Aconiti, 5-10 parts, Rhizoma et Radix Notopterygii 5-20 parts, Flos Carthami 5-10 parts, Radix Saposhnikoviae 10-20 parts, Ramulus Cinnamomi 5-10 parts, Ramulus Mori 2-5 parts, Rhizoma Atractylodis 5-10 parts, Radix Aconiti Lateralis Preparata 10-20 parts, Herba Epimedii 5-10 parts, Caulis Impatientis 10-20 parts, Radix Angelicae Pubescentis 10-20 parts, Radix Angelicae Dahuricae 10-20 parts and Herba Asari 10-20 parts. The combined drug of the invention achieves the potency of drug to be directly delivered to the focus through oral taking, local suffocating and foment and realizes good treatment effect.

Description

technical field [0001] The present invention relates to a medical preparation containing raw materials derived from plants, in particular to a combination medicine for treating synovitis. Background technique [0002] Rheumatoid arthritis is a chronic systemic immune disease characterized by joint synovitis. Small joints such as hands, fingers, and toes are most likely to be involved, with persistent and repeated attacks. In the early stage, the joints are red, swollen, hot, painful and dysfunctional, and in the late stage, the joints are ankylized or deformed, and even disabled. [0003] Rheumatoid arthritis is a very complex disease, and its pathogenesis is multifaceted. So far, the etiology of rheumatoid arthritis has not been fully elucidated. Rheumatoid arthritis is characterized by chronic synovitis. Characteristic, autoimmune disease that culminates in cartilage resorption, bone destruction, and bone fibrosis. The characteristic changes of synovial membrane in rheum...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8994A61P19/02A61P19/04A61P29/00
Inventor 杨纪英
Owner 杨纪英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products